Immunotherapy + CRT Boosts Response in Esophageal Cancer ...Middle East

Medscape - News
Immunotherapy + CRT Boosts Response in Esophageal Cancer
The addition of sintilimab to neoadjuvant chemoradiotherapy achieved a 60% pathological complete response rate vs 47.3% with chemoradiotherapy alone in locally advanced ESCC. Medscape Medical News

Hence then, the article about immunotherapy crt boosts response in esophageal cancer was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Immunotherapy + CRT Boosts Response in Esophageal Cancer )

Apple Storegoogle play

Last updated :

Also on site :